Navigation Links
Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
Date:8/7/2009

ce they are developed."

McEnany concluded, "Catalyst, along with leading addiction clinicians across the U.S., continues to seek governmental grants from the National Institutes of Health ("NIH"), the National Institute on Drug Abuse, and other agencies that operate under the NIH umbrella, for future vigabatrin addiction trials and to provide a portion of the required funding for our future clinical and non-clinical trials."

Publication of Phase II Mexican Cocaine Trial Results

A paper describing the positive results obtained in an investigator-initiated Phase II trial conducted in Mexico in 2007 was published on August 3, 2009 in the online edition of The American Journal of Psychiatry, a world leading peer-reviewed medical journal. The paper, entitled "Randomized, Double-Blind, Placebo-Controlled Trial of Vigabatrin for the Treatment of Cocaine Dependence in Mexican Parolees," was authored by Jonathan D. Brodie, M.D., Ph.D., Brady G. Case, M.D., Emilia Figueroa, M.D., Stephen L. Dewey, Ph.D., James A. Robinson, M.Ed., Joseph A. Wanderling, M.A. and Eugene M. Laska, Ph.D. The paper suggests that vigabatrin may be effective in the treatment of cocaine addiction. An abstract of the paper can be accessed by clicking here.

"We are extremely pleased that the results of this important trial have been published by a medical journal of this caliber," commented Mr. McEnany. "Catalyst is pleased to have provided financial support for this trial."

About Catalyst Pharmaceutical Partners

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Using catalysts to stamp nanopatterns without ink
2. Experiments reveal unexpected activity of fuel cell catalysts
3. UCT Specialties (Formerly Petrarch) Announces the Release of Their New Product Guides for Silanes, Silicones, Platinum Catalyst and Glass Coatings
4. IDEXX Laboratories Announces First Customer Deliveries of Catalyst Dx(TM) Chemistry Analyzer and SNAPshot Dx(TM) Analyzer
5. Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement
6. Controlling the size of nanoclusters: First step in making new catalysts
7. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
8. NIST and partners identify tiny gold clusters as top-notch catalysts
9. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
10. Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
11. PointCross Releases Catalyst for Building Business-Ready SharePoint Solutions in 1/10th the Time

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...N, Nov. 19 Danish Prince Joachim i...ethanol plant in Kalundborg, Denmark, on Wednesday...first and largest 2nd generation ethanol demonstra... are used in the plant,s innovative process for co...nisco, was the first to market with commercial enz...
(Date:11/19/2009)..., Nov. 19 NeoStem, Inc. ...nt the following letter to its shareholders, discu...09, of China Biopharmaceuticals Holdings, Inc. (CH...d in the People,s Republic of China. The merger gi...yre Pharmaceutical Co. Ltd., CHBP,s primary operat...
(Date:11/19/2009)..., Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. ... a randomized Phase 2B study of AEG35156, a target...for multiple oncology indications. ,, The study... of the X-Linked Inhibitor of Apoptosis (XIAP) Ant...e Cytarabine and Idarubicin in AML Following Failu...
(Date:11/19/2009)...VIENNA, Austria, November 19 AFFiR...n one product candidate at an unexpectedly early,s... planned to enter into,Phase II clinical trial ear...ly follows the completion of two Phase I trials wi... its fast decision on the first interim,analysis o...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...SQUAN, NJ., March 31 BioSpace, the world,s leadin...eer fair company, will host,the Biotech Beach(TM) ...The,event will take place at the Hyatt Regency La ....com/cgi-bin/prnh/20080222/CLF013LOGO ), Life sc...a will attend,the biotech job fair to meet in pers...
...POLIS, Md., March 31 PharmAthene, Inc.,(Amex: PI...rmeasures against,biological and chemical threats,...ed December 31, 2007., David P. Wright, President...e continued to advance both our corporate and prod...f important milestones which included,obtaining ad...
...ON, Mass., March 31 Tryton Medical, Inc., the,lea...ve treatment of,bifurcation lesions announced toda...of financing. Two new investors, PTV Sciences and ...re Partners in the financing. Rick Anderson,from P...inted to the Tryton,Board of Directors., "Bifurca...
Other Biology Technology:Bioscience Career Fair in San Diego Expected to Draw Record Jobseeker Attendance 2PharmAthene Reports Year-End 2007 Financial Results 2PharmAthene Reports Year-End 2007 Financial Results 3PharmAthene Reports Year-End 2007 Financial Results 4PharmAthene Reports Year-End 2007 Financial Results 5PharmAthene Reports Year-End 2007 Financial Results 6PharmAthene Reports Year-End 2007 Financial Results 7PharmAthene Reports Year-End 2007 Financial Results 8PharmAthene Reports Year-End 2007 Financial Results 9Tryton Medical, Inc. Closes $14 Million Financing 2Tryton Medical, Inc. Closes $14 Million Financing 3
(Date:11/20/2009)... single bacterial gene into yeast, researchers fro...s achieved three improvements in bioethanol produc...ol, less acetate and elimination of the major by-p...shed in the scientific journal Applied and Enviro...ol is made by the yeast Saccharomyces cerevisiae f...
(Date:11/20/2009)... Research Center (ERC) has been awarded a grant fr...methods of recovering and reusing the heat that wo...pression process in a carbon capture system. The g...n capture and sequestration, or storage (CCS), and... emitted into the atmosphere by coal-fired power p...
(Date:11/19/2009)...ists are revealing the genetic instructions inside... maize, has one of the most complex sequences of D...ison genomicist David Schwartz, who was one of mor...Science . , "The maize genome is a true maze fu...oubled would-be sequencers for years," says Schwar...
Breaking Biology News(10 mins):Delft breakthrough in bioethanol production from agricultural waste 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 1Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 2Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 3Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 4Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 5Kimberly Clark Announces Definitive Agreement to Acquire I Flow Corporation 59197 6Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 1Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 2Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 3Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 4Fresenius Medical Care N A Has Selected VitalRemedyMDs VitalProteinRx 28TM 29 As Its Bar of Choice for Protein Replacement in Dialysis Patients 5360 1Fresenius Medical Care N A Has Selected VitalRemedyMDs VitalProteinRx 28TM 29 As Its Bar of Choice for Protein Replacement in Dialysis Patients 5360 2
...HICAGO Research studies featured in the October 2...nclude: , Dietary Restraint and Gestational Wei...roves Folate Intake and Food-Related Behaviors in ..., Changes in Nutrient Intake and Dietary Quality a... Low-Fat Vegan Diet or a Conventional Diabetes Die...
...University of Illinois microbiology professor Will... way to mass-produce an antimalarial compound, pot...nsive. , Metcalf set out to understand how this...s made in nature by bacteria. He was interested in...e antibiotic properties. Recently, Metcalf and his...
...he global scientific community will gather in Mapu...l Assembly (GA) of the International Council for S...d in sub-Saharan Africa. , More than 250 leading ...r at this unique event to discuss and address how ... pressing challenges facing society, including: hu...
Other Biology News:News from the October 2008 Journal of the American Dietetic Association 2New way to make malaria medicine also first step in finding new antibiotics 2New way to make malaria medicine also first step in finding new antibiotics 3New way to make malaria medicine also first step in finding new antibiotics 4Global science community to gather in Mozambique 2
...or (PR) Competitor Assay Kits are ideal for studyi...g compounds using fluorescence polarization (FP). ...one transferase to the ligand binding domain of hu...rietary, fluorescently tagged progesterone ligand,...
Cardiovascular/Renal Profile from Novascreen-a Caliper Life Sciences Company
Neurological Profile from Novascreen-a Caliper Life Sciences Company
...matopoietic stem cells called monocytes. Osteoclas...d lowering the surrounding pH to an acidic level o... and the collagen degraded. Osteoclast differentia...phage Colony-Stimulating Factor (M-CSF) and Recept...
Biology Products: